Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Return on Sales (2019 - 2025)

Historic Return on Sales for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to 0.41%.

  • Exagen's Return on Sales fell 100.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.27% for FY2024, which is 1800.0% up from last year.
  • Exagen's Return on Sales amounted to 0.41% in Q3 2025, which was down 100.0% from 0.26% recorded in Q2 2025.
  • Over the past 5 years, Exagen's Return on Sales peaked at 0.2% during Q2 2024, and registered a low of 1.93% during Q2 2022.
  • Over the past 5 years, Exagen's median Return on Sales value was 0.41% (recorded in 2025), while the average stood at 0.57%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -14300bps in 2022, then soared by 15700bps in 2023.
  • Exagen's Return on Sales (Quarter) stood at 0.56% in 2021, then tumbled by -112bps to 1.18% in 2022, then surged by 66bps to 0.4% in 2023, then surged by 32bps to 0.28% in 2024, then plummeted by -49bps to 0.41% in 2025.
  • Its last three reported values are 0.41% in Q3 2025, 0.26% for Q2 2025, and 0.24% during Q1 2025.